Influx Healthtech bulk deals
NSE: INFLUXPharmaceuticals & Biotechnology
Share price at the NSE close on 28 Oct 2026. Previous close ₹253.85.
28 Oct: open ₹259.95, high ₹274.95, low ₹259.05
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹625 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 30.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 6.20
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 20.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 25,20095.2% delivered
Influx Healthtech bulk deals
None in the last 12 months, since 29 Oct 2025.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Friday 11 Jul 20252 firms · ₹5.09 Cr bought · ₹4.72 Cr soldNet bought ₹0.37 Cr
- Both waysISHAAN TRADEFIN LLPBought 1,77,600 at ₹176.76Sold 1,39,200 at ₹176.530.77% of the companyNet +38,400 shares₹3.14 Cr bought
- Both waysDEVI TRADERS LLPBought 1,10,400 at ₹177.10Sold 1,28,400 at ₹176.390.55% of the companyNet −18,000 shares₹1.96 Cr bought
Thursday 10 Jul 20251 firm · ₹2.24 Cr bought · ₹2.33 Cr soldNet sold ₹0.09 Cr
- Both waysDEVI TRADERS LLPBought 1,29,600 at ₹173.05Sold 1,33,200 at ₹175.140.58% of the companyNet −3,600 shares₹2.24 Cr bought
Wednesday 9 Jul 20252 firms · ₹2.40 Cr bought · ₹4.29 Cr soldNet sold ₹1.89 Cr
- Both waysR K STOCKHOLDING (P) LTD.Bought 1,200 at ₹150.00Sold 1,23,600 at ₹151.560.53% of the companyNet −1,22,400 shares₹0.02 Cr bought
- Both waysDEVI TRADERS LLPBought 1,42,800 at ₹166.92Sold 1,45,200 at ₹166.540.63% of the companyNet −2,400 shares₹2.38 Cr bought
Wednesday 25 Jun 20254 firms · ₹8.56 Cr bought · ₹0 soldNet bought ₹8.56 Cr
- BoughtROHAN GUPTABought 2,89,200 at ₹131.801.25% of the company₹3.81 Cr
- BoughtJAGDISHPRASHADSHARMABought 1,26,000 at ₹132.920.54% of the company₹1.67 Cr
- BoughtISHAAN TRADEFIN LLPBought 1,17,600 at ₹131.480.51% of the company₹1.55 Cr
- BoughtMANSI SHARE AND STOCK BROKING PRIVATE LIMITEDBought 1,20,000 at ₹127.210.52% of the company₹1.53 Cr
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 14 deals on record since listing on 25 Jun 2025.